Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hybutimibe PK in Severe Renal Impairment vs Healthy
CTR20232183Phase 4Completed
- Sponsor
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hybutimibe in hypercholesterolemia, sponsored by Zhejiang Hisun Pharmaceutical Co., Ltd.. Started Jul 2023; status: completed.
02
Drugs
hybutimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on CTR20232183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232183.